作者: Victor J. Dzau , Ruediger C. Braun-Dullaeus , Daniel G. Sedding
DOI: 10.1038/NM1102-1249
关键词:
摘要: In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well formation of fibrous cap that provides stability plaque. The VSMC can undergo a proliferative response underlies development in-stent restenosis, bypass graft occlusion transplant vasculopathy. Although benefit/risk therapeutic inhibition proliferation in atherosclerosis is unclear, experimental human evidence strongly suggests potential antiproliferative therapy for failure other disorders.